Peer Review History

Original SubmissionJune 4, 2025
Decision Letter - James R Faeder, Editor, Brittany Rife Magalis, Editor

 PCOMPBIOL-D-25-01117

Mechanistic within-host mathematical model of inhalational anthrax

PLOS Computational Biology

Dear Dr. Whaler,

Thank you for submitting your manuscript to PLOS Computational Biology. The manuscript as is was embraced enthusiastically. We would only ask that the authors please address Reviewer 2's concern regarding the controversial incubation times and the minor revisions noted by all three reviewers. We are, therefore, excited to invite you to submit a revised version of the manuscript that addresses these points.

​Please submit your revised manuscript within 60 days Sep 12 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at ploscompbiol@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pcompbiol/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

* A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. This file does not need to include responses to formatting updates and technical items listed in the 'Journal Requirements' section below.

* A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

* An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, competing interests statement, or data availability statement, please make these updates within the submission form at the time of resubmission. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter

We look forward to receiving your revised manuscript.

Kind regards,

Brittany Rife Magalis, Ph.D

Academic Editor

PLOS Computational Biology

James Faeder

Section Editor

PLOS Computational Biology

Additional Editor Comments:

The submitted manuscript was embraced enthusiastically. I would only as that the authors please address Reviewer 2's concern regarding the controversial incubation times and the minor revisions noted by all three reviewers.

Journal Requirements:

1) We ask that a manuscript source file is provided at Revision. Please upload your manuscript file as a .doc, .docx, .rtf or .tex. If you are providing a .tex file, please upload it under the item type u2018LaTeX Source Fileu2019 and leave your .pdf version as the item type u2018Manuscriptu2019.

2) Please upload all main figures as separate Figure files in .tif or .eps format. For more information about how to convert and format your figure files please see our guidelines: 

https://journals.plos.org/ploscompbiol/s/figures

3) Please amend your detailed Financial Disclosure statement. This is published with the article. It must therefore be completed in full sentences and contain the exact wording you wish to be published.

1) State the initials, alongside each funding source, of each author to receive each grant. For example: "This work was supported by the National Institutes of Health (####### to AM; ###### to CJ) and the National Science Foundation (###### to AM).".

If you did not receive any funding for this study, please simply state: u201cThe authors received no specific funding for this work.u201d

4) Kindly revise your competing statement to align with the journal's style guidelines: 'The authors declare that there are no competing interests.'

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: This is an interesting paper that considers an important problem of efficiently modelling within-host dynamics of bacterial anthrax. Using a clear mechanistic structure for disease transmission/progression in different parts of the body, they are then able to not just qualitative reproduce available data, but to actually fir their results to a number of model organisms, including rabbit, guinea pig, and even a known human outbreak. Overall, the paper is clear and well-written, and I am happy to recommend publication, provided the authors address the following minor issues related to improving clarity/readability.

1. While units of measurement for different parameters are stated in Table 1, perhaps it would be a good idea to also include them next to parameters themselves in the leftmost column of Table 2.

2. When introducing Sverdlovsk data on p. 13, it is advisable to mention straightaway the limitations of those data in terms of possible use of tetracycline in some patients, but with an unknown start date and unknown duration.

3. Perhaps, it would be a good idea to mention in Table 3 transitions for PA_{LN} and PA_C in the same way, as they are described for all other model compartments. Also, to be absolutely sure, do I understand correctly that the ODE system representing the mean-field model was not actually used for simulations, and instead it was rather the stochastic version that was simulated using Gillespie algorithm with transition probability as given in Table 3?

Reviewer #2: This is an interesting study on applying a mechanistic mathematical model of anthrax infection to data from experimental infections of animals. The insights from the animal data-based model are also applied toward exploring a model of human incubation time estimates, which is also interesting and useful. The details for the within-host model are novel extensions to prior models in this field, leading to novel conclusions.

While I have not checked all the details of the analysis and results, I have no reason to doubt that they were done correctly. The model and analysis techniques are well explained, the codes to reproduce the analysis are publicly available and appear to be well documented, and the results are plausible and not inconsistent with prior, related work. I think the model and techniques described are quite useful advancements for this area of work.

My only suggestion for improvement is regarding the human incubation time data from the 1979 Sverdlovsk infections. The authors use data from a 2006 manuscript by Wilkening, but there was later work that arguably produced a more rigorously derived list of incubation times. A 2012 study by National Academies Institute of Medicine (https://nap.nationalacademies.org/catalog/13218/prepositioning-antibiotics-for-anthrax) cast doubt on some of the incubation times from the Wilkening data set, particularly a few very short (< 4 days) incubation times that were from individuals with unconfirmed Anthrax infection. They judged that a list of incubation times from 31 autopsy-confirmed anthrax victims reported by Abramova et al. (https://doi.org/10.1073/pnas.90.6.2291) provided a stronger evidence base for incubation period distribution from this event.

I wonder if using applying the authors’ analysis to this set of 31 incubation times would lead to different conclusions compared to the result from the Wilkening data. I suggest the authors attempt this comparison if possible.

Reviewer #3: This was an excellent manuscript to read - very clearly written, solid modelling assumptions, with open and honest interpretation of the work, as well useful suggestions for future work. The authors were able to calibrate their model against experimental data, whilst reflecting on the limitations of their data and approach. Useful insights were generated, but again placed in an honest framework of what more needs to be done before the findings can be used in practice.

I have only two very minor points:

- the assumption that only 1CFU is produced by one chain of bacteria seems odd since the authors describe the chains of bacteria as being very long. Why would only 1CFU emerge from this? There's some discussion of this in the Methods, but a little more discussion here would be interesting.

- in Figure 2, two of the data points lie obviously outside of the range of the simulations. Can the authors comment on these? It's not unusual for the simulations to not be able to capture all the data (as is also the case elsewhere in the manuscript), but these two appear more extreme than data points later on that aren't captured.

**********

Have the authors made all data and (if applicable) computational code underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data and code underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data and code should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data or code —e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Prof Konstantin Blyuss

Reviewer #2: No

Reviewer #3: No

Figure resubmission:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. If there are other versions of figure files still present in your submission file inventory at resubmission, please replace them with the PACE-processed versions.

Reproducibility:

To enhance the reproducibility of your results, we recommend that authors of applicable studies deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols 

Revision 1

Attachments
Attachment
Submitted filename: response to reviewers.pdf
Decision Letter - James R Faeder, Editor, Brittany Rife Magalis, Editor

Dear Dr Whaler,

We are pleased to inform you that your manuscript 'Mechanistic within-host mathematical model of inhalational anthrax' has been provisionally accepted for publication in PLOS Computational Biology.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Computational Biology. 

Best regards,

Brittany Rife Magalis, Ph.D

Academic Editor

PLOS Computational Biology

James Faeder

Section Editor

PLOS Computational Biology

***********************************************************

Formally Accepted
Acceptance Letter - James R Faeder, Editor, Brittany Rife Magalis, Editor

PCOMPBIOL-D-25-01117R1

Mechanistic within-host mathematical model of inhalational anthrax

Dear Dr Whaler,

I am pleased to inform you that your manuscript has been formally accepted for publication in PLOS Computational Biology. Your manuscript is now with our production department and you will be notified of the publication date in due course.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript.

Soon after your final files are uploaded, unless you have opted out, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

Thank you again for supporting PLOS Computational Biology and open-access publishing. We are looking forward to publishing your work!

With kind regards,

Benedek Toth

PLOS Computational Biology | Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom ploscompbiol@plos.org | Phone +44 (0) 1223-442824 | ploscompbiol.org | @PLOSCompBiol

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .